A Study on Preoperative Diagnosis in Malignant Ovarian Tumor

1993 ◽  
Vol 4 (4) ◽  
pp. 90
Author(s):  
Seok Mo Kim ◽  
Ju Eun Cho ◽  
Jae Hyung Na ◽  
Sang Hoon Sohn ◽  
Hyun Jue Park ◽  
...  
2019 ◽  
Vol 3 (2) ◽  
pp. 130-136
Author(s):  
Arif Fadillah ◽  
Andi Friadi

Background : Malignant ovarian tumor are still the number one cause of death and the second most  of incidents for gynecological malignant tumors. The principles of management of ovarian cancer are the same as the principles of handling other malignant diseases, for the treatment of primary lesions operatively and the handling of potential sites of tumor metastases with chemotherapy. Histopathological examination is still considered a gold standard for diagnosis and definitive treatment of malignant ovarian tumors. If histopathologic results are obtained, then the patient will be planned to undergo postoperative chemotherapy. The mismatch between the preoperative and intraoperative clinical features, and the results of postoperative histopathological examination is a problem in managing cases of ovarian malignant tumors.Objective : Report a case of residive ovarian carcinoma with no appearance of malignancy marker in the previous postoperative histopathological examination.Method : Case reportCase : We report the case of a 45-year-old woman with a history of two previous laparotomy. The first operation was carried out in February 2014 on the indication of an extra ovarian cyst, resulting in the impression of a "Follicular Cysts" based on histopathological examination. The second operation was performed in March 2015, performed surgical staging tumors with an indication of malignant ovarian tumors with clinical metastases, but from histopathological examination it was found that "Cystadenoma Ovarii Muscinosum Multiloculare" and "no visible signs of malignancy", so the patient was not managed with postoperative chemotherapy. In April 2019 patients came with complaints of new mass growth, from CT-Scan and USG investigations there was a suspicious impression of a residive ovarian tumor with metastases into the omentum and massive ascites. On May 16, 2019 an optimal debulking was performed with the findings of residive mass, ascites, and mass metastases in the intra operative peritoneum. From the results of histopathological examination, it was found that "Muscinous Carcinoma with metastases to the umbilicus, peritoneum, and ascitic fluidKeywords: Malignant residive ovarian tumor, mucinous ovarian carcinoma


2016 ◽  
Vol 8 (1) ◽  
pp. 183-188 ◽  
Author(s):  
Yankun Li ◽  
Xiangchao Zeng

SELDI-TOF MS serum peptide profiles of malignant and benign ovarian tumor samples were studied using a pattern recognition technique.


1997 ◽  
Vol 120 (1) ◽  
pp. 109-115 ◽  
Author(s):  
Fumitaka Kikkawa ◽  
Koji Tamakoshi ◽  
Akihiro Nawa ◽  
Kiyosumi Shibata ◽  
Sadako Yamagata ◽  
...  

2008 ◽  
Vol 36 (8) ◽  
pp. 512-516 ◽  
Author(s):  
Shozo Yoshida ◽  
Akira Onogi ◽  
Hiroshi Shigetomi ◽  
Yoriko Tsuji ◽  
Shoji Haruta ◽  
...  

Author(s):  
Alberto Carlos Moreno Zaconeta ◽  
Maria de Fatima Brito Vogt ◽  
Laura Cardoso Vasconcelos

2016 ◽  
Author(s):  
Nikita Kumari ◽  
Reenu Kanwar ◽  
Bindu Bajaj ◽  
Garima Kapoor

Introduction: Ovarian fibrothecomas represent an ovarian stromal neoplasm developing in a wide spectrum of clinical settings. These tumors have been described as rare ovarian neoplasm, accounting for about 4% of all ovarian tumors. We report a case whose clinical presentation was highly deceptive and was clinically and radiologically diagnosed as malignant ovarian tumor. Ascitic fluid cytology revealed absence of malignant cells. On histopathological examination, it was diagnosed as benign fibrothecoma with cystic changes. Postoperative follow-up for about six months was uneventful. Case: A 45 year old female presented to the gynae emergency with large abdominal lump of 20 weeks size with acute pain abdomen. She was admitted for initial management and thorough evaluation. Hematological and biochemical parameters were within normal limits. USG revealed a large multilocular, predominantly cystic lesion 20.9x9.6x11.4 cm in pelvis. CECT revealed ovarian cystadencarcinoma left ovary with locoregional mass effect, mild ascites and suspicious metastasis to internal iliac lymph nodes. Radiological and preoperative clinical diagnosis was malignant ovarian tumor. Panhysterectomy and omentectomy was performed. On gross examination, a well encapsulated, multinodular cystic tumor of left ovary about 17x14x7 cm was identified. Cut surface was mostly solid with few cystic areas. Uterus, cervix, right ovary and both tubes were unremarkable. On microscopic examination, multiple sections showed spindle shaped cells in storiform and palisading pattern. No mitotic activity was identified. On special staining, it was positive for vimentin, which is a characteristic feature of ovarian fibrothecoma. Conclusion: The accurate preoperative diagnosis of ovarian fibrothecoma with cystic changes could have prevented the extensive surgical intervention such as bilateral salpingo- oopherectomy with hysterectomy.


2012 ◽  
Vol 46 (2) ◽  
pp. 102-103
Author(s):  
Lakhbir Dhaliwal ◽  
Neelam Aggarwal ◽  
Raje Nijhawan ◽  
Subhas Chandra Saha

ABSTRACT Background Angiomyxoma is a rare tumor arising from the pelvis. Preoperative diagnosis and treatment may be difficult. Case report We report a rare case of aggressive angiomyxoma pelvis that presented as vault prolapse and was misdiagnosed as ovarian tumor. Conclusion As surgery is the main treatment, preoperative diagnosis and assessment of extent of the tumor for planning surgery cannot be overemphasized. Synopsis Angiomyxoma is a rare pelvic tumor with varied presentation. Preoperative diagnosis and assessment of extent of the tumor are important for its management. How to cite this article Siwatch S, Saha SC, Aggarwal N, Dhaliwal L, Nijhawan R. Aggressive Angiomyxoma Pelvis Presenting as an Ovarian Tumor with Vault Prolapse. J Postgrad Med Edu Res 2012;46(2):102-103.


Sign in / Sign up

Export Citation Format

Share Document